RxDoctor Payments Data

William Jaffe

Orthopaedic Surgery · New York, NYNPI 1215033626

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $658,783 of the $661,196 with a category attached, or 99.6%. Stryker accounts for 97.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $298,283 and has fallen 98.1% since, to $5,524 in 2025. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$661,196in general payments, 2019–2025

Across 223 payments — averaging $2965.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$642K
  • Omnilife Science, Inc$7K
  • Corin USA$7K
  • Conmed Corporation$6K
  • Innovation Technologies Inc$73
$7,200in research payments, 2019–2025

Across 2 payments — averaging $3600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Corin USA$7K

What the payments were for

  • Consulting fees$658,783100%
  • Speaking & faculty fees$1240%
  • Travel & lodging$2,0390%
  • Food & beverage$2510%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker217$642,100
Omnilife Science, Inc3$6,900
Corin USA1$6,600
Conmed Corporation1$5,524
Innovation Technologies Inc1$73

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$661,196 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam11$55

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →